24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

lyman829

木虫 (正式写手)

应助: 19 (小学生)
金币: 3505.3
散金: 10
帖子: 437
在线: 1178.7小时
虫号: 470061
注册: 2007-11-29
性别: GG
专业: 合成药物化学

[交流] 【讨论】关于俄罗斯今年上市的一个新药已有7人参与

今年三月份，俄罗斯上市了一个抗流感的新药，商品名是ingavirin,俄语叫Ингавирин，但是居然找不到任何资料有结构报道，不知道各位对于这个药有什么高见，如能找到结构式就最好了

回复此楼

» 猜你喜欢

医药口服制剂辅料应用已经有0人回复
全新推出Tguide®靶向递送方案，突破99% T细胞转染效率已经有1人回复
药理学论文润色/翻译怎么收费? 已经有287人回复
Mal-LN29-LNP-mRNA 试剂盒：自带Mal基团，一盒实现抗体筛选与体内靶向验证已经有0人回复
自由偶联 | 脾脏靶向：抗体偶联空载LNP试剂盒已经有0人回复
SM-102 试剂盒，告别纳米制备仪！已经有0人回复
2026年辅料登记预告已经有1人回复
SPguide®：小鼠体内脾脏转染的一键解决方案已经有0人回复
高效肺靶向RNA转染，加速肺部RNA药物开发已经有2人回复
二糖的糖脂，合成后sephadex LH-20分离不出来，求助已经有1人回复

1楼 2009-08-12 22:55:24

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

stevesluo

木虫 (正式写手)

应助: 0 (幼儿园)
金币: 1855.3
散金: 5
红花: 1
帖子: 554
在线: 211.9小时
虫号: 695163
注册: 2009-02-02
性别: GG
专业: 药物设计与药物信息

★
小木虫(金币+0.5):给个红包，谢谢回帖交流

Dacarbazine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dacarbazine
Systematic (IUPAC) name
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Identifiers
CAS number 4342-03-4
ATC code L01AX04
PubChem 2942
DrugBank APRD00331
ChemSpider 10481959
Chemical data
Formula C6H10N6O
Mol. mass 182.18
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 hours
Excretion 40% renal (unchanged)
Therapeutic considerations
Pregnancy cat. C

Legal status ℞ Prescription only

Routes IV
Y(what is this?)  (verify)

Dacarbazine (da-KAR-ba-zeen) (brand names DTIC, DTIC-Dome; also known as DIC or Imidazole Carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas. Antineoplastic drugs are drugs which interfere with cell growth and impede the formation of new tissue - in this case, tumor tissue. These drugs are also known as cytotoxic drugs. Dacarbazine belongs to the family of chemicals known as alkylating agents. Dacarbazine is normally administered by injection (a shot) or intravenous infusion (IV) under the immediate supervision of a doctor or nurse.

Contents [hide]
1 History
2 Side effects
3 Common uses
4 Experimental
5 Suppliers
6 See also
7 Sources

[edit] History
See also: History of cancer chemotherapy
Dacarbazine gained FDA approval in May 1975 as DTIC-Dome. The drug was initially marketed by Bayer.

[edit] Side effects
Like many chemotherapy drugs, dacarbazine may have numerous serious side effects, because it interferes with normal cell growth as well as cancer cell growth. Among the most serious possible side effects are birth defects to children conceived or carried during treatment; sterility, possibly permanent; or immune suppression (reduced ability to fight infection or disease). Dacarbazine is considered to be highly emetogenic, and most patients will be pre-medicated with antiemetic drugs like palonosetron or aprepitant. Other significant side effects include headache, fatigue and occasionally diarrhea.

[edit] Common uses
As of mid-2006, dacarbazine is commonly used as a single agent in the treatment of metastatic melanoma, and as part of the ABVD chemotherapy regimen to treat Hodgkin lymphoma, and in the MAID regimen for sarcoma.

[edit] Experimental
Dacarbazine + Oblimersen. In clinical trials for malignant melanoma.

[edit] Suppliers
Bayer continues to supply DTIC-Dome. There are also generic versions of dacarbazine available from APP, Bedford, Mayne Pharma and Sicor (Teva).